CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Alza Corporation v. Mylan Pharmaceuticals Inc.

1:14-cv-00594

Overview

Case Number 1:14-cv-00594
Filing Date 2014-05-12
Status Terminated
Termination Date 2014-07-10
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Mylan Inc. Operating Company

Represented By

1 Attorneys Listed

Mary Matterer

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Mylan Pharmaceuticals Inc. Operating Company

Represented By

1 Attorneys Listed

Mary Matterer

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Plaintiff

Janssen Pharmaceuticals Inc. Operating Company

Represented By

3 Attorneys Listed

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Alza Corporation NPE (Individual / Inventor)

Represented By

9 Attorneys Listed

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Peter S. Choi

Email: peter.choi@sidley.com

Lisa A. Schneider

Email: lschneider@sidley.com

Jeffrey P. Kushan

Email: jkushan@sidley.com

James A. High

Email: jhigh@sidley.com

Fitz B. Collings

Email: fcollings@sidley.com

David T. Pritikin

Email: dpritikin@sidley.com

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 12 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 2 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (12): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (2 found):
U.S. Courts: 2
U.S. District Court 2013-06-24
1:13-cv-01126

Alza Corporation v. Osmotica Kereskedelmi es Szolgaltato Kft

Asserted Patent
Status: DED
U.S. District Court 2011-05-05
1:11-cv-00395

Alza Corporation v. Impax Laboratories, Inc.

U.S. Family Sibling (["US6930129"])
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8163798
Methods and devices for providing prolonged drug therapy
Filed: 2003-08-12
Issued: 2012-04-24
Expired (Term Ended)
Expires: 2020-10-29

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

2

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 2 Motion to Dismiss 2

Key Dispositive Motions & Rulings

Motion to Dismiss Pending / Under Review
MOTION to Dismiss for Lack of Jurisdiction Over the Person - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Matterer, Mary) (Entered: 06/23/2014)
Entry #10 • 2014-06-23 Document →
Motion to Dismiss Pending / Under Review
[SEALED] OPENING BRIEF in Support re 10 MOTION to Dismiss for Lack of Jurisdiction Over the Person filed by Mylan Inc., Mylan Pharmaceuticals Inc..Answering Bri...
Entry #11 • 2014-06-23 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 9 STIPULATION TO EXTEND TIME for Mylan Pharmaceuticals Inc. and Mylan Inc. to answer, move, or otherwise respond to the Complaint to June 23, 201...
Entry #— • 2014-06-02
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendants Mylan Pharmaceuticals Inc. and Mylan Inc. to answer, move, or otherwise respond to the Complaint for Patent Infringeme...
Entry #9 • 2014-05-30 Document →

Docket Entries

(22 total)
Pleading / Complaint

COMPLAINT filed against Mylan Inc., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 21392.) - filed by Alza Corporation, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Acknowledgement of Consent Form)(cla, ) (Entered: 05/12/2014)

Entry #1 • 2014-05-12
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 05/12/2014)

Entry #2 • 2014-05-12
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/2/14. Date of Expiration of Patent: 7/31/17.Thirty Month Stay Deadline: 10/2/2016. (cla, ) (Entered: 05/12/2014)

Entry #3 • 2014-05-12
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,163,798;. (cla, ) (Entered: 05/12/2014)

Entry #4 • 2014-05-12
1
Pleading / Complaint

SUMMONS Returned Executed by Alza Corporation, Janssen Pharmaceuticals Inc.. Mylan Pharmaceuticals Inc. served on 5/12/2014, answer due 6/2/2014. (Lydon, Tiffany) (Entered: 05/12/2014)

Entry #5 • 2014-05-12
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc